title: Effect of maternal antibodies and pig age on the antibody response after vaccination against Glässers disease.
abstract: The influence of age and maternal antibodies on the development and duration of postvaccinal antibody response against Glässer's disease were investigated. Pigs born to immune (MDA-positive) and non-immune (MDA-negative) sows were vaccinated with inactivated vaccine. Vaccination was done according to three different protocols: at 1 and 4, at 2 and 5 or at 4 and 7 weeks of age. There were also two control groups for MDA-negative and MDA-positive pigs. The level of Haemophilus parasuis (Hps) specific antibodies were determined using commercial ELISA test. No serological responses were seen in any of the groups after the first vaccination. Maternally derived antibodies (MDA) against Hps were above the positive level until approximately 3 weeks of life in MDA-positive pigs. In those pigs the strongest postvaccinal humoral response was observed in piglets vaccinated at 4 and 7 weeks of age. In the remaining MDA-positive piglets only slight seroconversion was noted but levels of antibodies never exceeded values considered as positive. All MDA-negative pigs produced Hps-specific antibodies after the second vaccination. The results of the present study indicated that MDA may alter the development and duration of active postvaccinal antibody response. Age of pigs at the moment of vaccination was not associated with the significant differences in the magnitude of antibody response, however influenced the kinetics of decline of Hps-specific antibodies.
authors.affiliation: Department of Swine Diseases, National Veterinary Research Institute, Puławy, Poland. mpomorska@piwet.pulawy.pl
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Pomorska-Mól
authors.forename: Iwona
authors.initials: I
authors.lastname: Markowska-Daniel
authors.forename: Jarosław
authors.initials: J
authors.lastname: Rachubik
authors.forename: Zygmunt
authors.initials: Z
authors.lastname: Pejsak
mesh_terms: D000367:Age Factors; D000818:Animals; D000831:Animals, Newborn / Q000097:blood / Q000254:growth & development / Q000276:immunology / Q000382:microbiology; D000907:Antibodies, Bacterial / Q000097:blood / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D005260:Female; D006192:Haemophilus Infections / Q000097:blood / Q000276:immunology / Q000382:microbiology / Q000662:veterinary*; D018073:Haemophilus Vaccines / Q000008:administration & dosage / Q000276:immunology*; D044137:Haemophilus parasuis; D056724:Immunity, Humoral / Q000276:immunology*; D007112:Immunity, Maternally-Acquired / Q000276:immunology*; D011897:Random Allocation; D034421:Sus scrofa; D013553:Swine Diseases / Q000097:blood / Q000276:immunology* / Q000382:microbiology; D013997:Time Factors; D014611:Vaccination / Q000662:veterinary
chemical_list: D000907:Antibodies, Bacterial; D018073:Haemophilus Vaccines